1. Home
  2. EXPO vs ALKS Comparison

EXPO vs ALKS Comparison

Compare EXPO & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPO
  • ALKS
  • Stock Information
  • Founded
  • EXPO 1967
  • ALKS 1987
  • Country
  • EXPO United States
  • ALKS Ireland
  • Employees
  • EXPO N/A
  • ALKS N/A
  • Industry
  • EXPO Professional Services
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXPO Consumer Discretionary
  • ALKS Health Care
  • Exchange
  • EXPO Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • EXPO 3.5B
  • ALKS 4.9B
  • IPO Year
  • EXPO 1990
  • ALKS 1991
  • Fundamental
  • Price
  • EXPO $68.99
  • ALKS $27.87
  • Analyst Decision
  • EXPO
  • ALKS Strong Buy
  • Analyst Count
  • EXPO 0
  • ALKS 14
  • Target Price
  • EXPO N/A
  • ALKS $41.29
  • AVG Volume (30 Days)
  • EXPO 446.8K
  • ALKS 1.9M
  • Earning Date
  • EXPO 10-23-2025
  • ALKS 10-23-2025
  • Dividend Yield
  • EXPO 1.71%
  • ALKS N/A
  • EPS Growth
  • EXPO N/A
  • ALKS 21.99
  • EPS
  • EXPO 1.99
  • ALKS 2.08
  • Revenue
  • EXPO $519,154,000.00
  • ALKS $1,505,296,000.00
  • Revenue This Year
  • EXPO $4.31
  • ALKS N/A
  • Revenue Next Year
  • EXPO $7.48
  • ALKS $1.66
  • P/E Ratio
  • EXPO $35.19
  • ALKS $13.19
  • Revenue Growth
  • EXPO 2.10
  • ALKS N/A
  • 52 Week Low
  • EXPO $63.81
  • ALKS $25.17
  • 52 Week High
  • EXPO $115.75
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • EXPO 41.72
  • ALKS 48.33
  • Support Level
  • EXPO $68.30
  • ALKS $26.40
  • Resistance Level
  • EXPO $71.03
  • ALKS $28.65
  • Average True Range (ATR)
  • EXPO 1.60
  • ALKS 1.13
  • MACD
  • EXPO -0.20
  • ALKS -0.20
  • Stochastic Oscillator
  • EXPO 13.14
  • ALKS 41.41

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: